ImmunityBio Inc (IBRX) Stock Price, Quote, News & History

IBRXNASDAQ
$8.48
0.020.24%
At close: Sep 18, 5:00 PM EST
$8.50
0.020.24%
After Hours: Sep 18, 7:52 PM EST

ImmunityBio (IBRX) Stock Price, Quote, News & History | Benzinga

Loading...

Key Statistics

Open
$8.46
Close
$8.48
Volume / Avg.
18.43M / 10.15M
Day Range
$8.20 - $8.53
52 Wk Range
1.95 - 12.43
Market Cap
$9.01B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
31.34%
Days to Cover
14.77

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-281.14M
Investing Cash Flow (TTM)
-276.91M
Financing Cash Flow (TTM)
496.78M
Free Cash Flow (TTM)
-288.51M
Capital Expenditure (TTM)
-7.38M
Net Change in Cash (TTM)
-61.26M

Analyst Trends and Forecast

2
Mar
2
Apr
3
May
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$9.46B
PE Ratio (TTM)
-
PE Ratio (FWD)
120.48
PEG Ratio (TTM)
-
PS Ratio (TTM)
51.16
PB Ratio (TTM)
-
Earnings Yield % (TTM)
-11.24%
Earnings Yield % (FWD)
0.83%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
-$0.99

Company Debt

Total Debt
$774.35M
LT Debt
$774.35M
LT Debt Issuance (TTM)
$61.00K
LT Debt Repayment (TTM)
-$49.00K
Total Cash
$75.67M
Debt to Equity
-
Issuance of Debt (TTM)
$12.00K
Repayment of Debt (TTM)
-$49.00K

Key Statistics

Open
$8.46
Close
$8.48
Volume / Avg.
18.43M / 10.15M
Day Range
$8.20 - $8.53
52 Wk Range
1.95 - 12.43
Market Cap
$9.01B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
31.34%
Days to Cover
14.77

About

Sector
Health Care
Industry
Biotechnology
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy ImmunityBio (IBRX) stock?

A

You can purchase shares of ImmunityBio (NASDAQ:IBRX) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for ImmunityBio (IBRX) stock?

A

ImmunityBio has a consensus price target of $14.63.

Q

What is the current price for ImmunityBio (IBRX)?

A

The stock price for ImmunityBio (NASDAQ: IBRX) is $8.5 last updated September 18, 2026 at 7:52 PM EDT.

Q

Does ImmunityBio (IBRX) pay a dividend?

A

There are no upcoming dividends for ImmunityBio.

Q

When is ImmunityBio (NASDAQ:IBRX) reporting earnings?

A

ImmunityBio does not have any upcoming earnings scheduled.

Q

Is ImmunityBio (IBRX) going to split?

A

There is no upcoming split for ImmunityBio.

Q

What sector and industry does ImmunityBio (IBRX) operate in?

A

ImmunityBio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.